GenBio Inc. Announces Filing of Provisional Patent Application for Its ImmuneResq{TM}
GenBio Inc. A Nutraceutical Aimed at Treating Inflammation and the Chronic Serious Conditions that Result ALISO VIEJO, CA, UNITED STATES, April 12, 2022 /EINPresswire.com/ — GenBio, Inc. is pleased to announce it has filed a provisional patent with the United States Patent Office (“USPTO”) and has (patent pending) status as of April 4th, 2022, on […]
